As part of Operation Warp Speed, which is developing vaccines for the COVID-19 coronavirus, pharmaceutical companies Pfizer and Moderna are rehearsing the process of registering vaccines for different administration sites. Pfizer, for example, is practicing delivering their vaccine throughout different administration sites and learning lessons to aid those who must dispense the vaccine. The training is taking place in 54 different locations.
Moderna is also going through training for their vaccine for different jurisdictions, although the storage requirements for their COVID-19 coronavirus vaccine are far less rigorous than for the Pfizer vaccine. Whereas the Pfizer vaccine must be stored at ultracold temperatures, such as with dry ice, the Moderna vaccine can be stored for longer times and at standard ice refrigeration temperatures. This long-term storage of the Moderna COVID-19 vaccine at standard refrigeration temperatures helps it remain stable when attempting to reach extremely rural areas with the vaccine. Both companies are learning from these training sessions for developing administration literature and videos.
About the Author
Jack Browne
Technical Contributor
Jack Browne, Technical Contributor, has worked in technical publishing for over 30 years. He managed the content and production of three technical journals while at the American Institute of Physics, including Medical Physics and the Journal of Vacuum Science & Technology. He has been a Publisher and Editor for Penton Media, started the firm’s Wireless Symposium & Exhibition trade show in 1993, and currently serves as Technical Contributor for that company's Microwaves & RF magazine. Browne, who holds a BS in Mathematics from City College of New York and BA degrees in English and Philosophy from Fordham University, is a member of the IEEE.